Recipharm AB and Adroit Science AB have entered a strategic collaboration under which Adroit will provide solid state characterization services to support Recipharm’s pharmaceutical development. The companies aim to speed and reduce the cost of development, as well as improve quality by combining expertise in formulation development, API development, chemical analysis and solid state characterization.  
 
“I am very excited about this collaboration,” said Carl-Johan Spak, executive vice president, Development & Technology at Recipharm. “With the addition of development services from Adroit, we will have a very competitive offering, which will help our customers to progress their projects in a highly efficient way.  Adroit Science AB has fast established itself as one of the leading providers of solid state characterization services in Northern Europe. Indeed, we can offer an even better service to our customers through this collaboration, including complete development from molecule to product.”
 
“Adroit Science and Recipharm have already cooperated in a number of successful projects, and this formal partnership marks the logical next step in the mutual development of our strategic relationship. We are delighted to join forces with a leading CDMO like Recipharm and predict that this will bring new opportunities in worldwide customer support,” said Hans Gredeby, chief executive officer of Adroit Science AB.